Brief: Medexus Pharmaceuticals Announces Normal Course Issuer Bid
May 14 (Reuters) - Medexus Pharmaceuticals Inc MDP.V :
* MEDEXUS PHARMACEUTICALS ANNOUNCES NORMAL COURSE ISSUER BID
* MEDEXUS PHARMACEUTICALS INC - COMPANY MAY PURCHASE UP TO
1.0
MILLION OF ITS ISSUED AND OUTSTANDING COMMON SHARES
Source text for Eikon: ID:nGNX8FX3lP
Further company coverage: MDP.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medexus Pharmaceuticals
See all newsCanada's Medexus Q4 revenue misses analyst expectations, net loss widens
Brief: Medexus Pharmaceuticals Q4 Revenue USD 24.652 Million Vs. IBES Estimate USD 25.6 Million
Canada Research Roundup: CAE, Medexus Pharmaceuticals, TCP Energy
Medexus Pharma Q2 revenue misses estimates
Brief: Medexus Pharmaceuticals Q2 Revenue USD 24.741 Million Vs. IBES Estimate USD 25.6 Million